Medical risks of off-label GLP-1 agonist use for weight loss

Medical experts are raising concerns regarding the widespread off-label use of weight-loss drugs like Ozempic without professional supervision. The trend highlights ongoing public health risks associated with rapid weight loss practices and the potential for misuse of prescription medications.